Cancer statistics, 2016
Reads0
Chats0
TLDR
Overall cancer incidence trends are stable in women, but declining by 3.1% per year in men, much of which is because of recent rapid declines in prostate cancer diagnoses, and brain cancer has surpassed leukemia as the leading cause of cancer death among children and adolescents.Abstract:
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.read more
Citations
More filters
Journal ArticleDOI
The role of immune checkpoint inhibition in the treatment of ovarian cancer.
TL;DR: In this article, the authors present emerging clinical data of completed trials of immune checkpoint inhibitors and review ongoing studies and evaluate approaches to improve treatment outcomes through the use of predictive biomarkers and patient selection.
Journal ArticleDOI
LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling.
TL;DR: It is reported that the lncRNA PVT1 promotes KLF5/beta-catenin signaling to drive TNBC tumorigenesis, uncover a new singaling pathway to mediate TNBC, and provide PVT 1 as a new target for improving treatment of TNBC.
Journal ArticleDOI
Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients
He Cheng,He Cheng,Chen Liu,Chen Liu,Jiahao Jiang,Jiahao Jiang,Guopei Luo,Guopei Luo,Yu Lu,Yu Lu,Kaizhou Jin,Kaizhou Jin,Meng Guo,Meng Guo,Zhenzhen Zhang,Jin Xu,Jin Xu,Liang Liu,Liang Liu,Quanxing Ni,Quanxing Ni,Xianjun Yu,Xianjun Yu +22 more
TL;DR: Cell‐free circulating tumor DNA (ctDNA) in plasma has been used as a potential noninvasive biomarker for various tumors and may have clinical value for determining metastatic pancreatic cancer treatment and monitoring the tumor response.
Journal ArticleDOI
Use of Alternative Medicine for Cancer and Its Impact on Survival
TL;DR: Although rare, AM utilization for curable cancer without any CCT is associated with greater risk of death, and independent covariates on multivariable logistic regression associated with increased likelihood of AM use included breast or lung cancer, higher socioeconomic status, Intermountain West or Pacific location, stage II or III disease, and low comorbidity score.
Journal ArticleDOI
Development and Validation of a Nomogram Prognostic Model for SCLC Patients.
TL;DR: A new nomogram prognostic model for SCLC patients that has a significantly higher prognostic accuracy than previously developed models, including the AJCC eighth edition TNM‐staging system.
References
More filters
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
SEER Cancer Statistics Review, 1975-2003
Lynn A. G. Ries,D. Harkins,Martin Krapcho,Angela B. Mariotto,Barry A. Miller,Eric J. Feuer,Limin X. Clegg,M. P. Eisner,Marie-Josèphe Horner,Nadia Howlader,Matthew J. Hayat,Benjamin F. Hankey,Brenda K. Edwards +12 more
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
TL;DR: The scientific evidence is incontrovertible: inhaling tobacco smoke, particularly from cigarettes, is deadly.
Journal ArticleDOI
Permutation tests for joinpoint regression with applications to cancer rates
TL;DR: A joinpoint regression model is applied to describe continuous changes in the recent trend and the grid-search method is used to fit the regression function with unknown joinpoints assuming constant variance and uncorrelated errors.
Book
International Classification of Diseases for Oncology
TL;DR: This list of diseases for oncology includes cancers of the central nervous system, as well as other types of diseases such as lymphoma, leukaemia, and so on.